105 related articles for article (PubMed ID: 24561703)
1. Pharmacokinetic evaluation of lisinopril-tryptophan, a novel C-domain ACE inhibitor.
Denti P; Sharp SK; Kröger WL; Schwager SL; Mahajan A; Njoroge M; Gibhard L; Smit I; Chibale K; Wiesner L; Sturrock ED; Davies NH
Eur J Pharm Sci; 2014 Jun; 56():113-9. PubMed ID: 24561703
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
Sharp S; Poglitsch M; Zilla P; Davies NH; Sturrock ED
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657
[TBL] [Abstract][Full Text] [Related]
3. Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.
Burger D; Reudelhuber TL; Mahajan A; Chibale K; Sturrock ED; Touyz RM
Clin Sci (Lond); 2014 Jul; 127(1):57-63. PubMed ID: 24506807
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
[TBL] [Abstract][Full Text] [Related]
5. Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.
Watermeyer JM; Kröger WL; O'Neill HG; Sewell BT; Sturrock ED
Biochem J; 2010 Apr; 428(1):67-74. PubMed ID: 20233165
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
[TBL] [Abstract][Full Text] [Related]
7. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
[TBL] [Abstract][Full Text] [Related]
8. Characterization of angiotensin I-converting enzyme from anterior gills of the mangrove crab Ucides cordatus.
Bersanetti PA; Nogueira RF; Marcondes MF; Paiva PB; Juliano MA; Juliano L; Carmona AK; Zanotto FP
Int J Biol Macromol; 2015 Mar; 74():304-9. PubMed ID: 25544039
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
[TBL] [Abstract][Full Text] [Related]
10. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
Natesh R; Schwager SL; Sturrock ED; Acharya KR
Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
[TBL] [Abstract][Full Text] [Related]
12. Catalytic properties of recombinant dipeptidyl carboxypeptidase from Escherichia coli: a comparative study with angiotensin I-converting enzyme.
Cunha CE; Magliarelli Hde F; Paschoalin T; Nchinda AT; Lima JC; Juliano MA; Paiva PB; Sturrock ED; Travassos LR; Carmona AK
Biol Chem; 2009 Sep; 390(9):931-40. PubMed ID: 19558329
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
14. Screening of inhibitors of angiotensin-converting enzyme (ACE) employing high performance liquid chromatography-electrospray ionization triple quadrupole mass spectrometry (HPLC-ESI-QqQ-MS).
Musharraf SG; Bhatti MS; Choudhary MI; Rahman AU
Eur J Pharm Sci; 2017 Apr; 101():182-188. PubMed ID: 28189816
[TBL] [Abstract][Full Text] [Related]
15. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
[TBL] [Abstract][Full Text] [Related]
16. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
[TBL] [Abstract][Full Text] [Related]
17. Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril.
Sáenz-Campos D; Bayés MC; Masana E; Martín S; Barbanoj M; Jané F
Methods Find Exp Clin Pharmacol; 1996 Oct; 18(8):533-8. PubMed ID: 9044242
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
20. New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme.
Sharma RK; Douglas RG; Louw S; Chibale K; Sturrock ED
Biol Chem; 2012 May; 393(6):485-93. PubMed ID: 22628311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
